Customer Service: Write to info1@cyno.co.in
Loading...
To provide you with a better shopping experience, our website is currently being upgraded.
为了提供更好的服务，我们的网站正在进行升级。
During this period, please place your order through our email info1@cyno.co.in directly or using the button below.
升级期间，请直接通过我们的邮箱 info1@cyno.co.in 下单，或点击下方按钮联系我们。
We appreciate your understanding and continued support.
感谢您的理解与支持。
DASATINIB-20mgDasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
DASATINIB-50mgDasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
DASATINIB-70mg Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL). Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
